why choose us

First received: November 20, 2023

Clinical Trial: A Study of LY3971297 in Healthy Participants and Participants With Obesity and Hypertension

Study Status: NOT_YET_RECRUITING

Recruit Status: NOT_YET_RECRUITING

Condition: Healthy

Study Type: INTERVENTIONAL


Official Title: A Single-ascending and Multiple-ascending Dose Study of LY3971297 in Healthy Participants and Participants With Obesity and Hypertension

Brief Summary: The purpose of this study is to measure side effects of LY3971297 injection administered under the skin in healthy participants and obese participants with high blood pressure (BP).Blood tests will be performed to check how much LY3971297 gets into the bloodstream and how long it takes the body to eliminate it.This is a 5-part study.The study duration will be approximately 60 days for Part A and approximately 90 days for Parts B, C, D, and E.

Read more